OncoSignatur Breast by Signatur Biosciences — Product Research | aVenture Research
OncoSignatur Breast is a breast-cancer prognostic test kit under development, and Signatur Biosciences' products and technology are not available for sale.
OncoSignatur Breast is designed for local testing at hospitals or clinical laboratories using existing standard qPCR machines and uses PCRchitectur to condense testing into a single qPCR reaction.
OncoSignatur Breast is an under-development breast-cancer prognostic test kit for local hospitals or clinical laboratories using standard qPCR machines.
AI-powered clinical tests for breast cancer treatment selection, integrating pathology and clinical data to predict recurrence risk and therapy response.
AI-powered clinical tests for breast cancer treatment selection, integrating pathology and clinical data to predict recurrence risk and therapy response.